α-Diaethylphosphono-capronsaeure | 30094-34-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: α-Diaethylphosphono-capronsaeure
• 英文别名: 2-(Diethoxyphosphinyl)hexanoic acid；2-diethoxyphosphorylhexanoic acid
• CAS: 30094-34-9
• 化学式: C₁₀H₂₁O₅P
• 分子量: 252.247
• InChiKey: YBXFFUSUJTXYFN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  16
• 可旋转键数：
  9
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  72.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  α-Diaethylphosphono-capronsaeure 在 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 为溶剂， 反应 0.5h， 生成 (S)-3-Methyl-2-{2-[1-((3aR,5R,5aS,8aS,8bR)-2,2,7,7-tetramethyl-tetrahydro-bis[1,3]dioxolo[4,5-b;4',5'-d]pyran-5-yl)-meth-(E)-ylidene]-hexanoylamino}-butyric acid methyl ester
  参考文献：
  名称：

  Coutrot, Philippe; Grison, Claude; Lecouvey, Marc, Bulletin de la Societe Chimique de France, 1997, vol. 134, # 1, p. 27 - 46

  摘要：

  DOI：

文献信息

• TRICYCLIC COMPOUND
  申请人：Daiichi Sankyo Company, Limited

  公开号：EP1939205A1

  公开（公告）日：2008-07-02

  The present invention relates to tricyclic compounds each represented by the following formula (I): (wherein, R1, R2, R2', R3, R4, X, Y and Z have the same meanings as defined in the specification); and a drug containing the compound. Since the compounds according to the present invention exhibit an excellent squalene synthetase inhibitory effect and cholesterol synthesis inhibitory effect so that they are useful as a drug such as preventive and/or remedy for diseases in mammals including humans such as hyperlipemia, e.g., hypercholesterolemia, hypertriglyceridemia, and low HDL cholesterolemia and/or arteriosclerosis.

  本发明涉及一种三环化合物，每种化合物由以下式（I）表示：（其中，R1、R2、R2'、R3、R4、X、Y和Z的含义与规范中定义的含义相同）；以及含有该化合物的药物。由于根据本发明的化合物表现出优异的角鲨烯合酶抑制作用和胆固醇合成抑制作用，因此它们可用作哺乳动物（包括人类）的疾病预防和/或治疗药物，例如高脂血症，如高胆固醇血症、高甘油三酯血症、低高密度脂蛋白胆固醇血症和/或动脉粥样硬化。
• Highly Regio- and Enantioselective Hydrogenation of Conjugated α-Substituted Dienoic Acids
  作者：Xian Liu、Song Liu、Quanjun Wang、Gang Zhou、Lin Yao、Qin Ouyang、Ru Jiang、Yu Lan、Weiping Chen

  DOI：10.1021/acs.orglett.0c00915

  日期：2020.4.17

  Highly regio- and enantioselective hydrogenation of conjugated α-substituted dienoic acids was realized for the first time using Trifer–Rh complex, providing a straightforward method for the synthesis of chiral α-substituted γ,δ-unsaturated acids. DFT calculations revealed N+H–O hydrogen bonding interaction is formed to stabilize the transition state and the coordination of 4,5-double bond to Rh(III)

  使用Trifer-Rh配合物首次实现了对共轭α-取代二烯酸的高度区域和对映选择性加氢，为合成手性α-取代的γ，δ-不饱和酸提供了一种简单的方法。DFT计算表明，形成N + H–O氢键相互作用可稳定过渡态，并且4,5-双键与Rh（III）中心的配位将促进还原消除过程。该氢化提供了沙比特利前体的克级合成。
• TRICYCLIC COMPOUNDS
  申请人：Sugita Kazuyuki

  公开号：US20090181942A1

  公开（公告）日：2009-07-16

  The present invention relates to tricyclic compounds each represented by the following formula (I): (wherein, R 1 , R 2 , R 2′ , R 3 , R 4 , X, Y and Z have the same meanings as defined in the specification); and a drug containing the compound. Since the compounds according to the present invention exhibit an excellent squalene synthetase inhibitory effect and cholesterol synthesis inhibitory effect so that they are useful as a drug such as preventive and/or remedy for diseases in mammals including humans such as hyperlipemia, e.g., hypercholesterolemia, hypertriglyceridemia, and low HDL cholesterolemia and/or arteriosclerosis.

  本发明涉及由以下公式（I）表示的三环化合物（其中，R1，R2，R2'，R3，R4，X，Y和Z的含义如说明书所定义）；以及含有该化合物的药物。由于本发明的化合物表现出优异的角鲨烷合酶抑制作用和胆固醇合成抑制作用，因此它们可用作哺乳动物（包括人类）疾病的预防和/或治疗药物，例如高脂血症、例如高胆固醇血症、高三酰甘油血症和低高密度脂蛋白胆固醇血症和/或动脉硬化。
• POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, MEMBRANE-ELECTROLYTE ASSEMBLY, AND SOLID POLYMER FUEL CELL USING SAME
  申请人：Toray Industries, Inc.

  公开号：EP3131145A1

  公开（公告）日：2017-02-15

  [Problem] To provide: a polymer electrolyte composition that has excellent chemical stability that makes it possible to withstand a strong oxidizing atmosphere during fuel cell operation, that makes it possible to achieve excellent protonic conductivity under low humidity conditions, excellent mechanical strength, and excellent physical durability, and that is highly practical; and a polymer electrolyte membrane, a membrane-electrode assembly, and a solid polymer fuel cell that use the polymer electrolyte composition. [Solution] A polymer electrolyte composition that comprises at least an ionic group-containing polymer (A), an organic phosphorus-based additive (C), and a nitrogen-containing heteroaromatic ring system additive (D) and that is characterized by the nitrogen-containing heteroaromatic ring system additive (D) comprising at least three nitrogen-containing heteroaromatic rings within a molecule thereof. In addition, the polymer electrolyte membrane, the catalyst layer-equipped electrolyte membrane, the membrane-electrode assembly, and the solid polymer fuel cell of the present invention are characterized by being configured using the polymer electrolyte composition.

  问题 提供一种聚合物电解质组合物，该组合物具有优异的化学稳定性，能够在燃料电池运行期间耐受强氧化性气氛，能够在低湿度条件下实现优异的质子电导率，具有优异的机械强度和优异的物理耐久性，并且具有很高的实用性；以及一种使用该聚合物电解质组合物的聚合物电解质膜、膜电极组件和固体聚合物燃料电池。[解决方案]一种聚合物电解质组合物，它至少包含一种含离子基团的聚合物（A）、一种有机磷基添加剂（C）和一种含氮杂芳香族环系添加剂（D），其特征在于含氮杂芳香族环系添加剂（D）在其分子内至少包含三个含氮杂芳香族环。此外，本发明的聚合物电解质膜、配备催化剂层的电解质膜、膜电极组件和固体聚合物燃料电池的特征在于使用聚合物电解质组合物进行配置。
• SUBSTITUIERTE 3-PHENYLPROPIONSÄUREN UND IHRE VERWENDUNG
  申请人：Bayer Pharma Aktiengesellschaft

  公开号：EP2493845A1

  公开（公告）日：2012-09-05